{"entity":{"type":"insider","cik":"0001969365","url":"/insider/0001969365","json_url":"/insider/0001969365.json","name":"Pimblett Emily","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":5,"first":"2024-06-21","last":"2025-06-20","span_basis":"filed_date"},"name_variants":[{"name":"Pimblett Emily","source":"filing","n_filings":5,"first_seen":"2024-06-21","last_seen":"2025-06-20"}],"transactions":[{"id":4027813,"accession":"0000950170-25-088524","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-088524","line_url":"/filing/0000950170-25-088524#line-2","is_derivative":false,"issuer_cik":"0001768446","issuer_name":"Climb Bio, Inc.","issuer_ticker":"CLYM","issuer_name_source":null,"issuer_url":"/issuer/0001768446","owner_cik":"0001969365","owner_name":"Pimblett Emily","owner_display_name":"Pimblett Emily","owner_url":"/insider/0001969365","role":"Officer (SVP, Finance & CAO)","role_mark":"O","role_mark_label":"Officer (SVP, Finance & CAO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Finance & CAO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1242.0,"shares_display":"1,242","price_per_share":1.24,"price_display":"1.24","price_state":"stated","total_value":1540.08,"total_display":"1,540.08","total_whole":"1,540","shares_owned_after":18888.0,"shares_owned_after_display":"18,888","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-20","filed_date":"2025-06-20","scope":"insider"},{"id":5117558,"accession":"0000950170-25-042777","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-042777","line_url":"/filing/0000950170-25-042777#line-2","is_derivative":false,"issuer_cik":"0001768446","issuer_name":"Climb Bio, Inc.","issuer_ticker":"CLYM","issuer_name_source":null,"issuer_url":"/issuer/0001768446","owner_cik":"0001969365","owner_name":"Pimblett Emily","owner_display_name":"Pimblett Emily","owner_url":"/insider/0001969365","role":"Officer (SVP, Finance & CAO)","role_mark":"O","role_mark_label":"Officer (SVP, Finance & CAO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Finance & CAO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1199.0,"shares_display":"1,199","price_per_share":1.31,"price_display":"1.31","price_state":"stated","total_value":1570.69,"total_display":"1,570.69","total_whole":"1,571","shares_owned_after":15130.0,"shares_owned_after_display":"15,130","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-20","filed_date":"2025-03-20","scope":"insider"},{"id":2595931,"accession":"0000950170-24-139052","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-139052","line_url":"/filing/0000950170-24-139052#line-2","is_derivative":false,"issuer_cik":"0001768446","issuer_name":"Climb Bio, Inc.","issuer_ticker":"CLYM","issuer_name_source":null,"issuer_url":"/issuer/0001768446","owner_cik":"0001969365","owner_name":"Pimblett Emily","owner_display_name":"Pimblett Emily","owner_url":"/insider/0001969365","role":"Officer (CHIEF ACCOUNTING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF ACCOUNTING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF ACCOUNTING OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1235.0,"shares_display":"1,235","price_per_share":2.02,"price_display":"2.02","price_state":"stated","total_value":2494.7,"total_display":"2,494.70","total_whole":"2,495","shares_owned_after":11329.0,"shares_owned_after_display":"11,329","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-19","filed_date":"2024-12-20","scope":"insider"},{"id":2418677,"accession":"0000950170-24-108582","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-24-108582","line_url":"/filing/0000950170-24-108582","is_derivative":false,"issuer_cik":"0001768446","issuer_name":"Eliem Therapeutics, Inc.","issuer_ticker":"ELYM","issuer_name_source":null,"issuer_url":"/issuer/0001768446","owner_cik":"0001969365","owner_name":"Pimblett Emily","owner_display_name":"Pimblett Emily","owner_url":"/insider/0001969365","role":"Officer (CHIEF ACCOUNTING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF ACCOUNTING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF ACCOUNTING OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1191.0,"shares_display":"1,191","price_per_share":8.179093198992444,"price_display":"8.18","price_state":"stated","total_value":9741.3,"total_display":"9,741.30","total_whole":"9,741","shares_owned_after":7573.0,"shares_owned_after_display":"7,573","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-20","filed_date":"2024-09-20","scope":"insider","n_lines":2},{"id":2190124,"accession":"0001415889-24-017799","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-017799","line_url":"/filing/0001415889-24-017799#line-2","is_derivative":false,"issuer_cik":"0001768446","issuer_name":"Eliem Therapeutics, Inc.","issuer_ticker":"ELYM","issuer_name_source":null,"issuer_url":"/issuer/0001768446","owner_cik":"0001969365","owner_name":"Pimblett Emily","owner_display_name":"Pimblett Emily","owner_url":"/insider/0001969365","role":"Officer (CHIEF ACCOUNTING OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF ACCOUNTING OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF ACCOUNTING OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1245.0,"shares_display":"1,245","price_per_share":7.2145,"price_display":"7.21","price_state":"stated","total_value":8982.0525,"total_display":"8,982.05","total_whole":"8,982","shares_owned_after":3755.0,"shares_owned_after_display":"3,755","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-20","filed_date":"2024-06-21","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":6,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":6,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":6},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001768446","name":"Climb Bio, Inc.","url":"/issuer/0001768446","role":"Officer (SVP, Finance & CAO)","n_filings":5,"first_seen":"2024-06-21","last_seen":"2025-06-20"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001969365","retrieved_at":"2026-08-23T22:31:02+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}